Clinical trial
Abilify as an Adjunctive Treatment for Refractory Depression
NCT00220636
Study timeline
Study start (unknown)2005-03-01Date precision: month
Registry last updated2016-05-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Depressive Disorder, Majorunresolved
Interventions
AripiprazoleDRUG
Sponsors & collaborators
St. Luke's-Roosevelt Hospital Centerlead sponsor
Bristol-Myers Squibbcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00220636 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.